SCHEMBL8281358

SCHEMBL8281358

Cc1cc(-c2ccc(F)c(N)c2)on1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ MAPT P10636 8/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TP53 P04637 6/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342160 0.83 KDM4E (0.49) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL8418311 0.83 CYP1A2 (0.46) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL12021736 0.80 CYP1A2 (0.44) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL8226298 0.79 CYP1A2 (0.43) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL2272084 0.77 CYP1A2 (0.54) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL28746964 0.77 CYP1A2 (0.54) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL27436300 0.75 ACHE (0.60) CYP2C9CYP2C19MAPTHSD17B10LMNA
SCHEMBL30955217 0.75 ACHE (0.60) CYP2C9CYP2C19MAPTHSD17B10LMNA
SCHEMBL7904001 0.73 MAPT (0.64) CYP2C9CYP2C19CYP1A2CYP19A1MAPT
SCHEMBL24799555 0.72 RPS6KB1 (0.52) CYP2C9CYP2C19CYP1A2CYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934227-B1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORP (US) 2011-12-21 — — EP disclosed
EP-1745047-B1 PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINE ADENOSINE-A2A- RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-03-24 — — EP disclosed
WO-2007035542-A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2007-03-29 — — WO disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 — — WO disclosed
Send feedback